ANNEXON, INC.

ANNX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $162.1M $49.5M $225.1M $140.0M $74.8M $268.6M $43.9M $44.2M
Accounts Receivable
Inventory
Total Current Assets $242.2M $316.5M $263.9M $248.1M $247.7M $354.0M $45.4M
Property, Plant & Equipment $10.6M $12.6M $14.8M $16.8M $17.8M $1.9M $2.1M
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $277.6M $350.1M $297.7M $285.1M $287.0M $355.9M $49.9M
Liabilities
Accounts Payable $14.9M $10.4M $5.5M $7.4M $11.2M $3.7M $2.4M
Total Current Liabilities $42.6M $30.5M $17.9M $22.4M $21.7M $10.6M $4.9M
Long-Term Debt
Total Liabilities $65.9M $57.0M $47.1M $53.9M $55.1M $11.7M $6.4M
Stockholders' Equity
Retained Earnings $-917.4M $-710.7M $-572.5M $-438.3M $-296.3M $-166.0M $-102.6M
Total Stockholders' Equity $211.6M $293.1M $250.6M $231.2M $231.9M $344.3M $-100.5M $-64.2M